Anxiety-depression after intravascular ultrasound-guided drug-coated balloon angioplasty dissection: Predictors and 12-month cardiovascular outcomes

Table 1 Baseline demographic and clinical characteristics, n (%)/mean ± SD

Characteristic	Anxiety-depression cohort (n = 65)	Stable cohort (n = 103)	P value
Age (years)	62.8 ± 10.5	64.5 ± 11.2	0.308
Female	34 (52.3)	34 (33.0)	0.013
BMI (kg/m2)	25.2 ± 3.1	24.8 ± 3.4	0.425
Current smoker	22 (33.8)	38 (36.9)	0.683
Hypertension	38 (58.5)	55 (53.4)	0.520
Diabetes mellitus	18 (27.7)	22 (21.4)	0.343
Hyperlipidemia	28 (43.1)	40 (38.8)	0.581
Prior MI	10 (15.4)	12 (11.7)	0.482
Prior PCI	15 (23.1)	20 (19.4)	0.566
Psychiatric history	12 (18.5)	4 (3.9)	0.002
Family psychiatric history	6 (9.2)	3 (2.9)	0.081
SSRS score	30.5 ± 8.2	41.2 ± 7.8	< 0.001
Pre-procedural HADS-A	8.2 ± 3.5	4.8 ± 2.2	< 0.001
Pre-procedural HADS-D	7.5 ± 3.2	4.2 ± 1.9	< 0.001
Pre-procedural GAD-7	9.0 ± 3.8	5.2 ± 2.5	< 0.001
Pre-procedural PHQ-9	8.5 ± 3.5	4.8 ± 2.2	< 0.001
LVEF (%)	55.2 ± 8.5	57.8 ± 7.2	0.105

BMI: Body mass index; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; SSRS: Social Support Rating Scale; HADS: Hospital Anxiety and Depression Scale; GAD-7: Generalized Anxiety Disorder-7; PHQ-9: Patient Health Questionnaire-9; LVEF: Left ventricular ejection fraction.